(Total Views: 527)
Posted On: 04/15/2020 9:05:34 AM
Post# of 149002
And I just noticed someone on the other board pointed this statement from today PR about basket trial ......
" Leronlimab will be administered subcutaneously as weekly dose of 350 mg.."
FDA didnt approve our combo for over 1 year now saying we can do better than 81% efficacy we have with 350 mg ...
And with those deadliest cancers , having already some safety with cancer with 350 and 700 mg ( M-i-L ) , in our ongoing studies , why at least not to go with 525 mg..
Explain please , they think we doing so well we don't need it...hard to believe..
Those are the things I have big problems with FDA...!!!!!!
" Leronlimab will be administered subcutaneously as weekly dose of 350 mg.."
FDA didnt approve our combo for over 1 year now saying we can do better than 81% efficacy we have with 350 mg ...
And with those deadliest cancers , having already some safety with cancer with 350 and 700 mg ( M-i-L ) , in our ongoing studies , why at least not to go with 525 mg..
Explain please , they think we doing so well we don't need it...hard to believe..
Those are the things I have big problems with FDA...!!!!!!
(7)
(1)Scroll down for more posts ▼
